scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.XPHS.2019.08.018 |
P698 | PubMed publication ID | 31469998 |
P50 | author | Tapan K. Das | Q51739364 |
P2093 | author name string | Li Tao | |
Zhi Chen | |||
Ming Zeng | |||
Xiang Cao | |||
Kaimeng Zhou | |||
Richard Ludwig | |||
James Bautista | |||
Neil Hershey | |||
P2860 | cites work | Characterization of succinimide stability during trypsin digestion for LC-MS analysis. | Q51105543 |
High throughput peptide mapping method for analysis of site specific monoclonal antibody oxidation. | Q51631949 | ||
Isomerization and Oxidation in the Complementarity-Determining Regions of a Monoclonal Antibody: A Study of the Modification-Structure-Function Correlations by Hydrogen-Deuterium Exchange Mass Spectrometry. | Q51739313 | ||
Subunit Mass Analysis for Monitoring Multiple Attributes of Monoclonal Antibodies | Q57031668 | ||
Validation of a peptide mapping method for a therapeutic monoclonal antibody: what could we possibly learn about a method we have run 100 times? | Q73524714 | ||
Fast analysis of recombinant monoclonal antibodies using IdeS proteolytic digestion and electrospray mass spectrometry | Q84148649 | ||
Isomerization in the CDR2 of a monoclonal antibody: Binding analysis and factors that influence the isomerization rate | Q84639225 | ||
Characterization and quantification of succinimide using peptide mapping under low-pH conditions and hydrophobic interaction chromatography | Q90024811 | ||
Separation of mAbs molecular variants by analytical hydrophobic interaction chromatography HPLC: overview and applications | Q26824543 | ||
The future of immune checkpoint therapy | Q28259862 | ||
Structure-based prediction of asparagine and aspartate degradation sites in antibody variable regions | Q28539968 | ||
Propensity for spontaneous succinimide formation from aspartyl and asparaginyl residues in cellular proteins | Q28618536 | ||
Molecular clocks | Q30327762 | ||
Formulation considerations for proteins susceptible to asparagine deamidation and aspartate isomerization. | Q30356718 | ||
Separation and characterization of an IgG2 antibody containing a cyclic imide in CDR1 of light chain by hydrophobic interaction chromatography and mass spectrometry | Q33324712 | ||
Mass spectrometry for structural characterization of therapeutic antibodies | Q33362439 | ||
Post-translational protein modifications in antigen recognition and autoimmunity | Q34319948 | ||
Protein therapeutics: a summary and pharmacological classification | Q34728463 | ||
Post-translational modifications in the context of therapeutic proteins | Q36620451 | ||
Heterogeneity of monoclonal antibodies | Q36935493 | ||
Post-translational modifications of recombinant proteins: significance for biopharmaceuticals | Q37104728 | ||
Characterization of therapeutic antibodies and related products. | Q38058362 | ||
The effect of cosolutes on the isomerization of aspartic acid residues and conformational stability in a monoclonal antibody | Q38305605 | ||
Ion-exchange chromatography for the characterization of biopharmaceuticals | Q38387706 | ||
Characterization of therapeutic antibodies and related products by two-dimensional liquid chromatography coupled with UV absorbance and mass spectrometric detection | Q38856515 | ||
Two-Dimensional Liquid Chromatography: A State of the Art Tutorial | Q39034187 | ||
Recent advances in (therapeutic protein) drug development. | Q39148639 | ||
Assessing analytical methods to monitor isoAsp formation in monoclonal antibodies | Q39252529 | ||
Isomerization of a single aspartyl residue of anti-epidermal growth factor receptor immunoglobulin gamma2 antibody highlights the role avidity plays in antibody activity | Q40018957 | ||
Isoaspartyl post-translational modification triggers anti-tumor T and B lymphocyte immunity. | Q40236620 | ||
Identification and characterization of deamidation sites in the conserved regions of human immunoglobulin gamma antibodies | Q40374080 | ||
Development of a quantitative mass spectrometry multi-attribute method for characterization, quality control testing and disposition of biologics | Q40724867 | ||
Direct identification of rituximab main isoforms and subunit analysis by online selective comprehensive two-dimensional liquid chromatography-mass spectrometry | Q40767411 | ||
Unexpected functional implication of a stable succinimide in the structural stability of Methanocaldococcus jannaschii glutaminase. | Q41345453 | ||
A Quadrupole Dalton-based multi-attribute method for product characterization, process development, and quality control of therapeutic proteins. | Q42280824 | ||
Identification of multiple sources of charge heterogeneity in a recombinant antibody. | Q43555101 | ||
Isomerization of an aspartic acid residue in the complementarity-determining regions of a recombinant antibody to human IgE: identification and effect on binding affinity. | Q45980125 | ||
Succinimide formation at Asn 55 in the complementarity determining region of a recombinant monoclonal antibody IgG1 heavy chain. | Q45993219 | ||
An improved trypsin digestion method minimizes digestion-induced modifications on proteins. | Q46003677 | ||
Direct identification and quantification of aspartyl succinimide in an IgG2 mAb by RapiGest assisted digestion | Q46161556 | ||
A View on the Importance of "Multi-Attribute Method" for Measuring Purity of Biopharmaceuticals and Improving Overall Control Strategy | Q46230442 | ||
Accumulation of succinimide in a recombinant monoclonal antibody in mildly acidic buffers under elevated temperatures | Q46541519 | ||
Intracellular protein modification associated with altered T cell functions in autoimmunity | Q48418429 | ||
Aspartate isomerization in the complementarity-determining regions of two closely related monoclonal antibodies. | Q51071625 | ||
P433 | issue | 1 | |
P304 | page(s) | 422-428 | |
P577 | publication date | 2019-08-27 | |
P1433 | published in | Journal of Pharmaceutical Sciences | Q3186933 |
P1476 | title | Structure-Function Assessment and High-Throughput Quantification of Site-Specific Aspartate Isomerization in Monoclonal Antibody Using a Novel Analytical Tool Kit | |
P478 | volume | 109 |
Search more.